Altria Group, Inc. (NYSE:MO) ranks among the top picks for a retirement portfolio. Altria Group, Inc. (NYSE:MO) and KT&G Corporation, a South Korean tobacco company, signed a non-binding memorandum of understanding on September 23 to work together on novel oral nicotine products, non-nicotine products, and conventional tobacco operating efficiency. The agreement includes plans to grow nicotine pouch products across the globe, including the possible extension of Altria’s on! and on! PLUS brands into selec ...

Altria Group, Inc. (NYSE:MO) is included among the 10 Highest Dividend-Paying Stocks to Buy in the S&P 500. Why Dividend Investors Keep an Eye on Altria Group’s (MO) Payouts Altria Group, Inc. (NYSE:MO) is an American company and one of the world’s leading producers and marketers of tobacco products, including cigarettes, as well as medical products designed to treat conditions related to tobacco use. The iconic company, best known for its Marlboro cigarettes, has long been a popular choice for dividend ...

The heavy dividend payer has already done well for investors so far in 2025.Investors are bulled up on hypergrowth technology stocks right now, especially anything related to artificial intelligence (AI). I would guess that many readers have large exposure to these AI stocks that have been massive winners in the last few years.There is nothing inherently wrong with allocating your portfolio to hypergrowth stocks. However, if you are an older or more conservative investor, now may be the perfect time to opti ...

Of the stocks that pay large dividends, the safest is probably the tobacco company Altria Group Inc. ...

Altria Group, Inc. (NYSE:MO) is included among the 12 Best Stocks to Buy Now for Passive Income.  How Altria Group (MO) Supports Long-Term Passive Income Goals Altria Group, Inc. (NYSE:MO) is an American company that specializes in the production and marketing of tobacco and related products. The company has seen sales volumes drop as smoking rates decline in the US, but the addictive nature of tobacco gives it pricing power that helps maintain steady cash flow. While relying on price hikes isn’t a long- ...

Core Insights - Altria Group, Inc. and Philip Morris International Inc. are leading companies in the global tobacco industry, with market capitalizations of approximately $109.5 billion and $255.3 billion respectively [1][2] - Both companies are heavily investing in next-generation products to adapt to declining cigarette volumes and increasing demand for smoke-free alternatives [3] Altria Group, Inc. (MO) - Altria's strong pricing power has allowed it to offset declines in cigarette volumes, with a net price realization of 10% in the smokeable products segment leading to adjusted operating companies income (OCI) growth of 4.2% in Q2 2025 [4] - The oral tobacco segment saw a 10.9% increase in adjusted OCI, with segment margins expanding 310 basis points to 68.7%, driven by the success of the on! nicotine pouch brand [5] - Adjusted earnings per share increased by 8.3% year over year to $1.44, supported by strong adjusted OCI growth and share repurchases, with Marlboro holding a 59.5% share in the premium category [6] - Domestic cigarette volumes fell 10.2% in Q2 2025, indicating ongoing industry declines and competitive pressure from flavored disposable e-vapor products [7] Philip Morris International Inc. (PM) - Philip Morris' smoke-free products accounted for 41% of total net revenues in Q2 2025, reflecting a 15.2% year-over-year increase, with IQOS, ZYN, and VEEV driving this growth [11] - Combustible net revenues advanced 2.1% in the quarter, supported by strong pricing power, while gross profit increased by 5% [12] - The company achieved over $500 million in gross cost savings in the first half of 2025, contributing to meaningful margin expansion [13] - Traditional cigarette volumes fell 1.5% year over year to 155.2 billion units, with management projecting a full-year decline of 2% [14] Financial Performance Comparison - The Zacks Consensus Estimate for Altria's 2025 EPS is $5.39, indicating a year-over-year increase of 5.3%, while Philip Morris' estimate remains at $7.50, suggesting growth of 14.2% [15] - Over the past year, Altria stock gained 27.7%, underperforming Philip Morris, which increased by 36% [16] Investment Outlook - Philip Morris is viewed as the stronger growth story due to its transition to smoke-free products and efficiency initiatives, while Altria offers stability and consistent performance [17]

I am focused on growth and dividend income. My personal strategy revolves around setting myself up for an easy retirement by creating a portfolio which focuses on compounding dividend income and growth. Dividends are an intricate part of my strategy as I have structured my portfolio to have monthly dividend income which grows through dividend reinvestment and yearly increases. Feel free to reach out to me on Seeking AlphaAnalyst’s Disclosure:I/we have a beneficial long position in the shares of VICI, NNN, M ...

Core Insights - Altria Group has entered a global memorandum of understanding with KT&G Corporation to collaborate on oral nicotine, wellness products, and efficiency improvements in traditional tobacco operations [1][9] Strategic Partnership - The partnership allows Altria to diversify revenue streams beyond cigarettes while enabling KT&G to leverage Altria's distribution network for global expansion [2] - Altria's subsidiary will acquire an ownership interest in Another Snus Factory Stockholm AB, coinciding with KT&G's acquisition of the same [3] Product Expansion and Market Entry - The collaboration aims to grow global demand for pouch products, including Altria's on! and on! PLUS brands [3] - Through KT&G's Korea Ginseng Corporation, the partners will explore entry into the U.S. energy and wellness market, combining KGC's expertise with Altria's retail presence [4] Operational Efficiency - Altria and KT&G will share best practices to enhance efficiency in cigarette manufacturing and supply chains, which may also support international nicotine product growth [5] Financial Performance - Altria's smokeable products segment achieved a net price realization of 10% in Q2 2025, leading to a 4.2% increase in adjusted operating income and a margin expansion of 290 basis points to 64.5% [6] - Marlboro brand expanded its market share in the premium category to 59.5%, demonstrating effective brand management [7] - The on! nicotine pouch brand saw a 26.5% increase in shipments in Q2, with adjusted operating income rising by 10.9% and margins expanding by 310 basis points to 68.7% [8] Market Challenges - Domestic cigarette shipments decreased by 10.2% in Q2, reflecting industry-wide declines and increased competition from flavored disposable e-vapor products [10]

Core Viewpoint - Altria Group, known for its Marlboro brand, faces an uncertain future despite its history of consistent dividend increases and dominance in the tobacco market [1][2]. Industry Transition - The tobacco industry is shifting from combustible cigarettes to smoke-free products, with Altria's ability to adapt to these trends being crucial for its long-term viability [2][5]. - The U.S. tobacco market remains lucrative, with Altria holding a 41% share of the retail cigarette market and 59.5% of the premium segment [4]. Product Development Challenges - Altria has struggled to establish itself in the next-generation product categories, including electronic vapes and heated tobacco devices, following a failed investment in Juul and a recent patent loss [5][6][7]. - Oral nicotine salt pouches have been Altria's most successful smoke-free product, but it still lags behind competitors like Philip Morris International's Zyn [8]. Financial Performance - In Q2 2025, approximately 83% of Altria's operating income came from smokeable products, indicating that smoke-free products are not yet a significant revenue source [9]. - The legacy smokeable segment remains profitable, allowing Altria to slowly increase free cash flow per share through price hikes and stock repurchases [10]. Dividend and Growth Outlook - Altria recently raised its dividend by 3.9%, offering a starting yield of 6.5%, with analysts projecting an average earnings growth of 3.4% annually over the next three to five years [11][12]. - The company is expected to maintain steady dividend growth for at least another five years, provided it can improve its performance in next-generation products [12]. Distribution Network Advantage - Altria's extensive distribution network, built through its Marlboro brand, positions it to potentially regain market share in new product categories if it executes effectively [13]. Investment Considerations - Altria is considered a strong high-yield dividend stock, appealing to investors seeking steady income, though it may not be suitable for those looking for high growth and capital gains [14][15]. - The company must enhance its product rollout and market presence in the transitioning nicotine industry to secure its long-term position [16].

Group 1 - Altria has entered into a non-binding memorandum of understanding with KT&G to expand nicotine pouches [4] - KT&G Corporation is recognized as South Korea's leading tobacco company [4] - KT&G's main business activities include the production, distribution, and sale of tobacco products [4]